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Abstract
Background: Cervical cancer incidence and mortality may be reduced by organized screening. Participant
compliance with the attendance recommendations of the screening program is necessary to achieve this.
Knowledge about the predictors of compliance is needed in order to enhance screening attendance.
Methods: The Norwegian Co-ordinated Cervical Cancer Screening Program (NCCSP) registers all cervix cytology
diagnoses in Norway and individually reminds women who have no registered smear for the past three years to
make an appointment for screening. In the present study, a questionnaire on lifestyle and health was administered
to a random sample of Norwegian women. The response rate was 68%. To address the predictors of screening
attendance for the 12,058 women aged 25-45 who were eligible for this study, individual questionnaire data was
linked to the cytology registry of the NCCSP. We distinguished between non-attendees, opportunistic attendees
and reminded attendees to screening for a period of four years. Predictors of non-attendance versus attendance
and reminded versus opportunistic attendance were established by multivariate logistic regression.
Results: Women who attended screening were more likely than non-attendees to report that they were aware of
the recommended screening interval, a history of sexually transmitted infections and a history of hormonal
contraceptive and condom use. Attendance was also positively associated with being married/cohabiting, being a
non-smoker and giving birth. Women who attended after being reminded were more likely than opportunistic
attendees to be aware of cervical cancer and the recommended screening interval, but less likely to report a
history of sexually transmitted infections and hormonal contraceptive use. Moreover, the likelihood of reminded
attendance increased with age. Educational level did not significantly affect the women’s attendance status in the
fully adjusted models.
Conclusions: The likelihood of attendance in an organized screening program was higher among women who
were aware of cervical screening, which suggests a potential for a higher attendance rate through improving the
public knowledge of screening. Further, the lower awareness among opportunistic than reminded attendees
suggests that physicians may inform their patients better when smears are taken at the physician’s initiative.
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Most cervical cancers are preceded by clinically asymp-
tomatic preinvasive lesions that are caused by sexually
transmitted human papillomaviruses (HPV) [1]. The
mortality from cervical cancer has declined in several
developed countries over the last decades [2], particu-
larly in countries with organized cervical screening pro-
grams [3]. Cervical screening can reduce the cervical
cancer incidence and mortality by detection and treat-
ment of preinvasive lesions, and of invasive lesions at
earlier, more curable stages.
The countries with the highest attendance to cervical
screening have organized programs which keep track of
the women’s screening status and remind women to be
screened. Most countries, however, do not have an orga-
nized screening program and thus rely on opportunistic
screening in which the initiative to be screened is left to
the women [2]. It has generally been found that the
probability of not attending screening is higher among:
older women [4], single women [5], women with low
socio-economic status [6], women with little interaction
with the health system [7] and women with little knowl-
edge of screening [8]. Other factors that sometimes have
been shown to be associated with screening attendance
include ethnicity [9], psychological barriers [10], urban/
rural residence and smoking [11].
Most of the studies that address attendance to cervical
screening employ data from an opportunistic screening
setting and rely on self-report of screening behavior [2].
Hence, there is a relative shortage of studies with qual-
ity-assured data on attendance, as well as studies that
address the determinants of attendance in an organized
screening setting. Even in countries with organized
screening, many women are screened opportunistically,
i.e. without receiving a reminder from the program,
because they attend at least as frequently as the recom-
mended interval. Little is known about what charac-
terizes the different types of screening attendees in
countries with an organized program.
The aim of the present study was to investigate factors
associated with attendance and non-attendance to the
organized cervical screening program in Norway. Such
knowledge is necessary to increase attendance rates. We
further wanted to investigate factors associated with
reminded versus opportunistic attendance to screening
in this setting.
Methods
Screening setting
The Norwegian Co-ordinated Cervical Cancer Screening
Program (NCCSP) was initiated in 1995 and the Cancer
Registry in Norway is responsible for the management
of the program. All laboratories which analyze cytologi-
cal smears in Norway are legally obliged to report the
result of each smear to the NCCSP. Smear results are
registered by a personal identification number (PIN)
which is unique to each Norwegian citizen. The NCCSP
individually reminds women aged 25-69 who have not
had a smear for the past three years to make an
appointment for smear-taking. Reminder letters also
contain basic information about screening and cervical
cancer. All women of eligible age are included in the
NCCSP unless they have informed the program that
they do not wish to participate, or have had a gynecolo-
gical cancer diagnosis or have had their cervix removed.
A woman receives her first letter from the NCCSP the
year she turns 25. Eligible women who have no regis-
tered smear during the last three years receive a remin-
der 37 months after her last registered smear. If no
smear is registered during the 12 months following the
first reminder, a second reminder is sent 49 months
after her last registered smear. The NCCSP does not
contact women who have had a smear during the last
three years. A woman has to pay circa € 20 for a smear
at a general practitioner. There is no disincentive to
more frequent screening than the NCCSP recommends.
Data sources
A self-administrated questionnaire was mailed to a ran-
dom sample of women aged 18-45 during November
2004 - June 2005 [12]. The questionnaire was also avail-
able on the web through the use of a personal access
code. The survey was designed to establish baseline
characteristics of lifestyle and health among females
aged 18-45 before the introduction of the vaccine
against HPV. It included women from Denmark, Ice-
l a n d ,N o r w a ya n dS w e d e n ,b u tt h ep r e s e n ts t u d yo n l y
included the Norwegian participants. The sample was
randomly drawn by the National population register. A
reminder was sent to women who did not respond
within four weeks. Those who still did not respond were
contacted by phone and asked to answer the questions
in a telephone interview. The response rates were 66.2,
70.1, 69.3 and 67.0% for the age groups 25-29, 30-34,
35-39 and 40-45, respectively. Most women included in
the study responded to the mailed questionnaire
(80.6%), whereas 10.4% responded via the web-based
questionnaire and 9.0% via interview.
All questions were pretested by an external group of
women to ensure clarity. To gain information about
screening attendance, the questionnaire data was linked
by PIN to the NCCSP databases, which contain informa-
tion about all smears taken in Norway.
Survey participation
A total of 25,001 Norwegian women aged 18-45 years
were asked to participate, among which 577 were
excluded because they had died or were not reached at
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consisted of 24,424 women. Among these, 2,409 women
explicitly stated they did not want to participate in the
study, and another 5,411 women did not return the
questionnaire, leaving 16,604 responding women (68%).
Individual information about the women not participat-
ing in the survey was limited to age and residence. Since
women eligible for NCCSP are aged 25-69, responders
below age 25 were excluded from this study (N =
4,428). In addition, 29 women with a discrepancy in the
reported PIN, 20 women who had stated they did not
want to receive reminders from the NCCSP, 49 women
with gynecological cancer, and 20 women who had had
their cervix removed were excluded.
The women were informed about the study in a cover
letter which included statements that the data would be
linked to health registries and that answering the ques-
tionnaire constituted consent to participate. Only
authorized personnel at the Cancer Registry of Norway
had access to the PINs of the women asked to partici-
pate in the survey. To protect the participants’ privacy,
all analyses were performed with de-identified data. The
study was approved by the Norwegian Data Inspectorate
and the Regional Committee for Medical and Health
Research Ethics.
Attendance definitions
Attendance to cervical screening was based on each
woman’s cytological smear history as recorded in the
NCCSP databases. Women were categorized as atten-
dees if they had had at least one smear during the last
four years and as non-attendees if no smear was
recorded in the same interval.
Opportunistic attendees were defined as women who
were not sent a reminder by the NCCSP within one
year prior to attendance, whereas reminded attendees
were defined as women who were sent a first or second
reminder within one year prior to attendance.
Statistics
Odds ratios with corresponding 95% confidence inter-
vals were derived from logistic regression models. The
significance of independent variables was assessed by
likelihood ratio tests, reported as P-values associated
with a corresponding difference in deviance assuming a
chi-square distribution.
The a-level was 0.05. Non-attendance versus atten-
dance, and reminded attendance versus opportunistic
attendance were modeled as separate dichotomous
response variables. For each response variable, we per-
formed one age-adjusted model per independent vari-
able, as well as one fully adjusted model in which all
independent variables that proved significant in the age-
adjusted models were included.
Results
Overall, non-participants and participants in the survey
were similar with respect to age, residential region and
the median household income of their residential muni-
cipality, although a slightly higher proportion of non-
participants than participants lived in Oslo and in muni-
cipalities with the lowest median income (Table 1). A
total of 12,058 women participated in the survey. Their
mean age was 34.8 years (SD = 5.9). A total of 13.4% (N
= 1,614) of the participating women had not attended
screening during the last four years, and were hence
classified as non-attendees (Table 2). The remaining
86.6% (N = 10,444) had attended screening during the
last four years and were classified as attendees. Among
attendees, 51.5% (N = 5,375) were opportunistic atten-
dees and 48.5% (N = 5,069) were reminded attendees.
Overall, there was good concordance in attendance sta-
tus between the study participants and the total popula-
tion in 2004, although the rate of women classified as
non-attendees was somewhat higher in the total popula-
tion (Table 2).
Non-attendance versus attendance
Age influenced the level of attendance to cervical
screening in a univariate model, mainly through a lower
attendance in the youngest age group than in the older
age groups. However, this effect disappeared in the fully
adjusted model (Table 3). The level of attendance
decreased with a decreasing level of education. This
association proved significant in the age-adjusted model,
but not in the fully adjusted model (Table 3). Women
with < 9, 9-12 and 13-16 years of education did not dif-
fer in attendance in the latter model, but women with
>16 years of education had a somewhat higher level of
attendance than women with 13-16 years of education.
Marital status strongly affected attendance in the age-
adjusted model, in which divorced/widowed women and
single women were less likely to attend than married/
cohabiting women (Table 3). Marital status similarly
influenced attendance in the fully adjusted model, but
here only the single women were significantly less likely
to attend than the married/cohabiting women.
Self-rated health was associated with attendance in the
age-adjusted model, in which women reporting poor,
good or excellent health all attended less than women
reporting very good health (Table 3). The same pattern
was evident in the fully adjusted model, although the
individual contrasts in some cases fell short of signifi-
cance. Smoking influenced attendance in both kinds of
models (Table 3). In the age-adjusted model, former
smokers attended more and current smokers attended
less than never smokers. In the fully adjusted model, for-
mer smokers did not differ from never smokers, but cur-
rent smokers attended significantly less than never
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Page 3 of 13smokers. The frequency of beer and liquor drinking did
not differ between attendees and non-attendees (Table
3). Wine drinking habits, on the other hand, were asso-
ciated with attendance (Table 3). In the age-adjusted
model, the likelihood to attend increased with an increas-
ing frequency of wine drinking. Wine drinking signifi-
cantly influenced attendance in the fully adjusted model
too, although the only significant single contrast was the
lower attendance among never-drinkers compared to
women drinking wine 1-3 times per month.
There was an increase in attendance with an increas-
ing number of lifetime coital partners, but this relation-
ship did not reach significance in the fully adjusted
model (Table 3). The number of recently acquired coital
partners was not associated with attendance (Table 3).
Increasing age at coital debut was associated with a
decrease in attendance in the age-adjusted model, but
not in the fully adjusted model (Table 3). Ever having
been diagnosed with an STI was strongly associated
with attendance both in the age-adjusted and the fully
adjusted model; women who had been diagnosed with
an STI were more likely to have attended screening
than were women who had not been diagnosed with an
STI (Table 3).
Women who ever had been pregnant had a somewhat
higher level of attendance than women who never had
been pregnant, but this association proved significant
only in the age-adjusted model (Table 3). Women who
h a dg i v e nb i r t hw e r em o r el i k e l yt oh a v ea t t e n d e d
screening than women who had not given birth, both in
the age-adjusted and the fully adjusted model, although
there did not seem to be an increase in attendance with
an increasing number of births (Table 3). Ever having
used hormonal contraceptives was among the strongest
predictors of attendance, ever-use being associated with
a far higher attendance rate than never-use in both
kinds of models (Table 3). Similarly, recent hormonal
contraceptive use and ever-use of condoms were asso-
ciated with higher attendance (Table 3).
Women who knew that a gynecological smear may
detect changes that could lead to cervical cancer had a
higher attendance rate than women without this
Table 1 Characteristics of non-participants and participants in the questionnaire survey
Frequency (%) among non-
participants (N = 5,628)
Frequency (%) among
participants (N = 12,058)
Age group (years)
25-29 25.3 23.4
30-34 22.7 24.7
35-39 24.1 25.3
40-45 27.9 26.7
Residential region in Norway
Oslo (capital) 18.1 15.4
Eastern (minus Oslo) 36.9 38.5
Western 29.2 28.7
Northern 15.8 17.4
Median income in residential municipality (NOK)
1
240,000-290,000 20.2 17.8
290,001-310,000 18.4 17.7
310,001-320,000 17.3 17.1
320,001-360,000 22.1 23.0
360,001-450,000 22.0 24.3
1 Data from Statistics Norway on the 2005 median income per household in the women’s residential municipality. There are 430 municipalities in Norway
Table 2 Attendance status according to age (N, %)
Age Nonattendees Spontaneous attendees Reminded attendees Total
Study
sample
Total
population
2004
Study
sample
Total
population
2004
Study
sample
Total
population
2004
Study
sample
Total
population
2004
25 - 29 502 (17.8) 44,885 (28.2) 1,406 (49.9) 63,830 (40.1) 912 (32.3) 50,592 (31.7) 2,820 (100) 159,307 (100)
30 - 34 347 (11.7) 36,407 (20.4) 1,401 (47.0) 74,559 (41.8) 1,230 (41.3) 67,270 (37.8) 2,978 (100) 178,236 (100)
35 - 39 375 (12.3) 35,684 (20.1) 1,275 (41.9) 68,215 (38.4) 1,395 (45.8) 73,792 (41.5) 3,045 (100) 177,691 (100)
40 - 45 390 (12.1) 36,900 (20.7) 1,293 (40.2) 63,710 (35.8) 1,532 (47.7) 77,554 (43.5) 3,215 (100) 178,164 (100)
Total 1,614 (13.4) 153,876 (22.2) 5,375 (44.6) 270,314 (39.0) 5,069 (42.0) 269,208 (38.8) 12,058 (100) 693,398 (100)
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N Non-attendance
(%)
Age-adjusted OR
(95% CI) for
non-attendance
Multivariate
a OR
(95% CI) for
non-attendance
SOCIODEMOGRAPHICS
Age
25-29 2820 17.80 1 1
30-34 2978 11.65 0.61 (0.53, 0.71) 0.92 (0.76, 1.12)
35-39 3045 12.32 0.65 (0.56, 0.75) 1.14 (0.93, 1.40)
40+ 3215 12.13 0.64 (0.55, 0.74) 1.00 (0.80, 1.25)
P-value P < 0.0001 P = 0.21
Education (years)
< 9 258 20.54 1.79 (1.29, 2.43) 0.94 (0.57, 1.48)
9-12 3226 15.22 1.26 (1.11, 1.43) 1.04 (0.88, 1.23)
13-16 5235 12.91 1 1
>16 3238 11.83 0.91 (0.79, 1.04) 0.81 (0.69, 0.96)
P-value P < 0.0001 P = 0.06
Marital status
Married/cohabiting 9201 11.27 1 1
Divorced/widow 784 14.54 1.40 (1.13, 1.73) 1.15 (0.87, 1.52)
Single 1975 22.78 2.18 (1.92, 2.47) 1.38 (1.16, 1.65)
P-value P < 0.0001 P = 0.002
HEALTH AND HEALTH RISKS
Self-rated health
Poor 852 19.01 1.84 (1.51, 2.22) 1.26 (0.97, 1.63)
Good 3645 14.32 1.28 (1.13, 1.45) 1.16 (0.99, 1.35)
Very good 5494 11.65 1 1
Excellent 1809 14.26 1.27 (1.09, 1.49) 1.38 (1.14, 1.66)
P-value P < 0.0001 P = 0.005
Smoking
Never 5435 13.21 1 1
Former 2684 9.84 0.73 (0.63, 0.85) 0.94 (0.78, 1.13)
Current 3899 16.03 1.26 (1.12, 1.42) 1.41 (1.20, 1.66)
P-value P < 0.0001 P < 0.0001
Beer drinking
Never 2626 11.00 0.96 (0.82, 1.12)
<once per month 3336 13.01 1.08 (0.93, 1.24)
1-3 times per month 3788 12.46 1
>=once per week 944 13.45 1.08 (0.87, 1.33)
P-value P = 0.46
Wine drinking
Never 966 17.39 1.55 (1.28, 1.87) 1.34 (1.06, 1.68)
<once per month 2884 14.08 1.22 (1.06, 1.40) 1.13 (0.96, 1.33)
1-3 times per month 4947 11.91 1 1
>=once per week 2187 9.83 0.84 (0.71, 0.99) 0.93 (0.77, 1.12)
P-value P < 0.0001 P = 0.03
Liquor drinking
Never 3597 12.29 1.02 (0.89, 1.17)
<once per month 4716 12.30 1
>=once per month 1827 12.97 1.03 (0.87, 1.21)
P-value P = 0.92
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Page 5 of 13Table 3 Odds ratios (OR) and 95% confidence intervals (CI) for non-attendance versus attendance to cervical screening
(Continued)
SEXUAL HISTORY
Number of lifetime coital partners
0-3
b 3992 15.98 1 1
4-9 4265 12.64 0.76 (0.67, 0.86) 1.02 (0.87, 1.21)
10 + 3423 11.01 0.65 (0.57, 0.74) 0.85 (0.69, 1.04)
P-value P < 0.0001 P = 0.09
Number of new coital partners during last six months
0 9696 13.26 1
1 1691 14.02 1.03 (0.89, 1.20)
2+ 572 12.94 0.90 (0.69, 1.16)
P-value P = 0.65
Age at first coitus
<17 4997 11.43 1 1
17-18 4023 13.05 1.18 (1.04, 1.34) 1.07 (0.92, 1.26)
19 + 2673 14.18 1.28 (1.12, 1.47) 0.99 (0.81, 1.20)
P-value P = 0.001 P = 0.54
Ever had any STI
c
No 8061 15.15 1 1
Yes 3627 9.15 0.57 (0.50, 0.64) 0.66 (0.56, 0.78)
P-value P < 0.0001 P < 0.0001
PREGNANCY AND CONTRACEPTIVES
Ever pregnant
No 2300 23.57 2.44 (2.14, 2.76) 1.21 (0.94, 1.56)
Yes 9720 10.92 1 1
P-value P < 0.0001 P = 0.13
Number of births
0 3133 21.54 1 1
1 2307 11.10 0.46 (0.39, 0.54) 0.62 (0.48, 0.82)
2 4013 9.54 0.38 (0.33, 0.44) 0.57 (0.44, 0.74)
3+ 2419 10.87 0.44 (0.37, 0.52) 0.59 (0.44, 0.78)
P-value P < 0.0001 P = 0.0006
Ever used hormonal contraceptives
No 1305 31.72 3.84 (3.36, 4.38) 2.12 (1.75, 2.58)
Yes 10670 11.12 1 1
P-value P < 0.0001 P < 0.0001
Used hormonal contraceptive during last month
No 7825 15.49 1 1
Yes 4097 9.37 0.53 (0.47, 0.60) 0.69 (0.60, 0.81)
P-value P < 0.0001 P < 0.0001
Ever used condoms
No 1873 21.41 2.13 (1.87, 2.42) 1.38 (1.15, 1.65)
Yes 10079 11.81 1 1
P-value P < 0.0001 P = 0.0007
AWARENESS
“Did you know that a gynecological smear may detect changes that could lead to cervical cancer?”
No 1224 23.37 2.04 (1.76, 2.35) 1.20 (0.96, 1.50)
Yes 10769 12.20 1 1
P-value P < 0.0001 P = 0.11
“Did you know that the recommended screening interval is every third year?”
No 1179 25.36 2.31 (1.99, 2.67) 1.39 (1.12, 1.72)
Yes 10835 12.04 1 1
P-value P < 0.0001 P = 0.003
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Page 6 of 13knowledge, but the association was significant only in
the age-adjusted model (Table 3). Having knowledge of
the recommended screening interval was associated with
higher attendance, even in the fully adjusted model
(Table 3).
The strongest predictor of cervical screening atten-
dance in our data was the women’s opinion on the neces-
sity to have a gynecological smear every third year (Table
3). Women who did not believe that a test every third
year was necessary for them attended screening more
than women who believed it was necessary. In contrast,
women who answered they did not know attended
screening less frequently than women who believed it
was necessary. These effects were pronounced and highly
significant even in the fully adjusted model. Finally, hav-
ing heard of HPV was associated with a somewhat higher
attendance, but this association did not reach significance
in the fully adjusted model (Table 3).
Reminded attendance versus opportunistic attendance
Whether women attended screening opportunistically or
after receiving a reminder from the screening program
depended on age, since the level of reminded attendance
generally increased with age, both in the age-adjusted
and in the fully adjusted model (Table 4). However, we
did not find any effect of the women’s educational level
(Table 4). Divorced/widowed as well as single women
tended to have a lower level of reminded attendance than
married/cohabiting women, although this association was
not significant in the fully adjusted model (Table 4). Self-
rated health, smoking and alcohol drinking did not influ-
ence the level of reminded versus opportunistic atten-
dance in the fully adjusted model (Table 4).
Women who reported 0-3 lifetime coital partners had
a higher level of reminded attendance than women who
reported more partners, both in the age-adjusted and
the fully adjusted models (Table 4). There were no sig-
nificant associations for the number of recently acquired
partners (Table 4). An increasingly advanced age at first
coitus was associated with a higher level of reminded
attendance, but significantly so only in the age-adjusted
m o d e l( T a b l e4 ) .O n eo ft h es t r o n g e s tp r e d i c t o r so f
reminded versus opportunistic attendance was ever hav-
ing been diagnosed with an STI (Table 4). Women who
reported a previous STI diagnosis had a lower level of
reminded attendance than did women who reported not
to have been diagnosed with an STI.
Ever having been pregnant did not influence the level
of reminded versus opportunistic screening attendance
(Table 4). The same was true for the number of births
given (Table 4). Women who reported to ever have
used hormonal contraceptives had a lower level of
reminded attendance than women who never had used
hormonal contraceptives (Table 4). Similarly, women
who had used hormonal contraceptives during the last
month were less likely to have been reminded to attend
than were women who had not used it recently (Table
4). Both predictors of hormonal contraceptive use
proved significant in the age-adjusted as well as the fully
adjusted model. Ever-use of condoms was associated
with a lower level of reminded attendance compared to
never-use, but significantly so only in the age-adjusted
model (Table 4).
Women with knowledge that a smear may detect
changes that could lead to cancer and women with
knowledge about the recommended screening interval
were more likely to have received a reminder before
they attended screening than women lacking this knowl-
edge, both in the age-adjusted and in the fully adjusted
model (Table 4). However, the women’so p i n i o no nt h e
necessity for them to have a smear every third year did
not significantly influence the fully adjusted model
( T a b l e4 ) .F i n a l l y ,w o m e nw h oh a dn o th e a r do fH P V
were more likely to have received a reminder before
attending screening than were women who had heard of
HPV (Table 4).
Table 3 Odds ratios (OR) and 95% confidence intervals (CI) for non-attendance versus attendance to cervical screening
(Continued)
“Do you believe a gynecological smear every third year is necessary for you?”
No 8733 9.58 0.50 (0.44, 0.56) 0.52 (0.45, 0.61)
Yes 2382 17.72 1 1
Don’t know 883 38.05 2.75 (2.32, 3.27) 2.19 (1.75, 2.74)
P-value P < 0.0001 P < 0.0001
“Have you ever heard of HPV?”
No 7664 14.08 1.22 (1.09, 1.36) 0.98 (0.85, 1.13)
Yes 4290 11.91 1 1
P-value P = 0.0006 P = 0.73
a The multivariate model only included variables that were significant in the age-adjusted models
b Included 154 women reporting zero lifetime coital partners
c Chlamydia, gonorrhea, trichomonas vaginalis, herpes or genital warts
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Page 7 of 13Table 4 Odds ratios (OR) and 95% confidence intervals (CI) for attendance to cervical screening after receipt of a
reminder, versus opportunistic attendance on own initiative
N Reminded
attendance
(%)
Age-adjusted OR (95% CI)
for reminded attendance
Multivariate
a OR (95% CI)
for reminded attendance
SOCIODEMOGRAPHICS
Age
25-29 2318 39.34 1 1
30-34 2631 46.75 1.35 (1.21, 1.52) 1.24 (1.09, 1.41)
35-39 2670 52.25 1.69 (1.51, 1.89) 1.58 (1.39, 1.80)
40+ 2825 54.23 1.83 (1.63, 2.04) 1.66 (1.45, 1.90)
P-value P < 0.0001 P < 0.0001
Education (years)
< 9 205 49.76 1.06 (0.80, 1.40)
9-12 2735 50.16 1.02 (0.92, 1.12)
13-16 4559 48.41 1
>16 2885 47.25 1.02 (0.88, 1.06)
P-value P = 0.77
Marital status
Married/cohabiting 8164 49.47 1 1
Divorced/widow 670 47.31 0.82 (0.70, 0.96) 0.88 (0.73, 1.06)
Single 1525 44.59 0.90 (0.81, 1.01) 0.95 (0.83, 1.08)
P-value P = 0.01 P = 0.33
HEALTH AND HEALTH RISKS
Self-rated health
Poor 690 46.23 0.86 (0.73, 1.00)
Good 3123 47.26 0.93 (0.85, 1.01)
Very good 4854 49.01 1
Excellent 1551 49.39 1.00 (0.89, 1.12)
P-value P = 0.12
Smoking
Never 4717 50.03 1 1
Former 2420 47.07 0.86 (0.78, 0.95) 0.97 (0.87, 1.09)
Current 3274 47.37 0.88 (0.81, 0.97) 1.03 (0.92, 1.15)
P-value P = 0.003 P = 0.66
Beer drinking
Never 2311 49.94 1.16 (1.04, 1.29) 1.05 (0.93, 1.18)
<once per month 2902 49.93 1.13 (1.02, 1.25) 1.05 (0.94, 1.17)
1-3 times per month 3316 46.47 1 1
>=once per week 817 45.53 0.96 (0.82, 1.12) 1.03 (0.87, 1.22)
P-value P = 0.008 P = 0.84
Wine drinking
Never 798 50.88 1.19 (1.02, 1.38) 1.17 (0.98, 1.39)
<once per month 2478 50.12 1.13 (1.02, 1.24) 1.08 (0.96, 1.21)
1-3 times per month 4358 47.22 1 1
>=once per week 1972 47.36 0.92 (0.83, 1.03) 0.96 (0.85, 1.08)
P-value P = 0.002 P = 0.13
Liquor drinking
Never 3155 49.57 1.01 (0.92, 1.11)
<once per month 4136 48.77 1
>=once per month 1590 46.04 0.92 (0.82, 1.03)
P-value P = 0.26
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Page 8 of 13Table 4 Odds ratios (OR) and 95% confidence intervals (CI) for attendance to cervical screening after receipt of a
reminder, versus opportunistic attendance on own initiative (Continued)
SEXUAL HISTORY
Number of lifetime coital partners
0-3
b 3354 54.03 1 1
4-9 3726 47.07 0.76 (0.70, 0.84) 0.88 (0.79, 0.99)
10 + 3046 44.42 0.69 (0.62, 0.76) 0.87 (0.76, 0.99)
P-value P < 0.0001 P = 0.05
Number of new coital partners during last six months
0 8410 49.27 1
1 1454 46.77 0.94 (0.84, 1.05)
2+ 498 42.77 0.84 (0.70, 1.01)
P-value P = 0.11
Age at first coitus
<17 4426 46.07 1 1
17-18 3498 48.66 1.10 (1.01 1.20) 1.07 (0.97, 1.19)
19 + 2294 52.14 1.26 (1.14, 1.40) 1.07 (0.94, 1.22)
P-value P < 0.0001 P = 0.36
Ever had any STI
c
No 6840 51.40 1 1
Yes 3295 42.12 0.68 (0.63, 0.74) 0.76 (0.68, 0.83)
P-value P < 0.0001 P < 0.0001
PREGNANCY AND CONTRACEPTIVES
Ever pregnant
No 1758 45.68 1.08 (0.97, 1.21)
Yes 8659 49.16 1
P-value P = 0.17
Number of births
0 2458 45.04 1
1 2051 46.03 0.92 (0.82, 1.04)
2 3630 49.89 0.96 (0.86, 1.08)
3+ 2156 52.97 1.03 (0.90, 1.17)
P-value P = 0.35
Ever used hormonal contraceptives
No 891 57.35 1.39 (1.21, 1.60) 1.21 (1.01, 1.46)
Yes 9483 47.63 1 1
P-value P < 0.0001 P = 0.03
Used hormonal contraceptive during last month
No 6613 50.20 1 1
Yes 3713 45.33 0.87 (0.80, 0.95) 0.88 (0.80, 0.96)
P-value P = 0.001 P = 0.006
Ever used condoms
No 1472 54.28 1.23 (1.10, 1.38) 1.07 (0.94, 1.23)
Yes 8889 47.54 1 1
P-value P = 0.0003 P = 0.31
AWARENESS
“Did you know that a gynecological smear may detect changes that could lead to cervical cancer?”
No 938 40.94 0.78 (0.68, 0.90) 0.78 (0.65, 0.94)
Yes 9455 49.25 1 1
P-value P = 0.0006 P = 0.007
“Did you know that the recommended screening interval is every third year?”
No 880 33.18 0.54 (0.47, 0.63) 0.49 (0.41, 0.59)
Yes 9531 49.96 1 1
P-value P < 0.0001 P < 0.0001
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Awareness of screening and cervical cancer
More than 90% of the women were familiar with the
function of the cervical smear and the recommended
screening interval. Having this knowledge markedly
increased attendance. However, the effects were wea-
kened in the fully adjusted model on non-attendance
versus attendance, showing that knowledge of screening
was associated with some of the other variables that also
were associated with the outcome. The same variables
were also strong predictors of reminded versus opportu-
nistic attendance, and attending women who were una-
ware of the smear and of the recommended screening
interval were more likely to have attended opportunisti-
cally. Thus, some opportunistically screened women
probably had a smear at the initiative of their physician
without appreciating the rationale for the test. This sug-
gests a need for more screening information from the
physician, especially when the smear is taken at the phy-
sician’s initiative. Further, our finding indicates that
reminders containing basic facts about screening may
have an educational function.
The answer to the question “Do you believe a gyneco-
logical smear every third year is necessary for you?” was
the strongest predictor of non-attendance versus atten-
dance. Nearly two thirds of the women answered nega-
tively to the question and, surprisingly, they were more
likely to attend than women who answered positively.
This finding indicates that the motivation for attendance
often does not depend strongly on the perception of
being at risk for cervical cancer. A negative answer may
reflect awareness that most women are not treated for
cervical cancer or its precursors, a fact that often will be
supported by personal experience. Women who regu-
larly have attended screening and have had normal
smears may perceive that they are not at high risk, and
consequently that the recommended screening interval
in their case is too short. Further, the high frequency of
negative answers suggests that most women readily will
accept an increased screening interval, which is a likely
scenario if HPV-testing is introduced in primary screen-
ing [13]. The fact that many non-attendees believed that
attendance at the recommended interval was necessary
for them suggests that they have motivation to be
screened, which is encouraging in terms of the efforts to
increase attendance. However, women who did not
attend were also far more likely not to have an opinion
on the subject, which probably reflects low awareness of
cervical screening.
Risk behavior
It is important to know whether screening attendance
differs according to established risk factors for cervical
cancer. We found that current smokers were more likely
to be non-attendees. Since smoking seems to be an
independent co-factor for HPV progression [14], this
indicates that non-attendees to cervical screening may
be at an additional risk because they are more likely to
be current smokers.
Sexual behavior is a major risk factor for HPV infec-
tion [1] and thus the development of cervical cancer,
but we found no indication that women who reported a
high number of partners, or who had their coital debut
at an early age, had a lower attendance rate than other
women. Other studies have also failed to find such asso-
ciations [11,15]. However, women who reported never
to have used condoms attended screening less than
women who had used condoms. Condoms may offer
some protection against the development of HPV-
related lesions [16] and it is thus possible that non-
attendees to cervical screening in Norway may be at a
higher risk for HPV exposure through less condom use.
Never-use of condoms may, however, be associated with
having had few sex partners, but note that the associa-
tion to non-attendance was significant when controlling
for other variables, including the number of partners. It
Table 4 Odds ratios (OR) and 95% confidence intervals (CI) for attendance to cervical screening after receipt of a
reminder, versus opportunistic attendance on own initiative (Continued)
“Do you believe a gynecological smear every third year is necessary for you?”
No 7896 49.23 1.14 (1.03, 1.26) 1.06 (0.93, 1.20)
Yes 1960 45.66 1 1
Don’t know 547 49.73 1.25 (1.04, 1.52) 1.13 (0.89, 1.43)
P-value P = 0.02 P = 0.54
“Have you ever heard of HPV?”
No 6585 49.70 1.14 (1.05, 1.24) 1.19 (1.08, 1.30)
Yes 3779 46.44 1 1
P-value P = 0.001 P = 0.0003
a The multivariate model only included variables that were significant in the age-adjusted models
b Included 154 women reporting zero lifetime coital partners
c Chlamydia, gonorrhea, trichomonas vaginalis, herpes or genital warts
Hansen et al. BMC Public Health 2011, 11:264
http://www.biomedcentral.com/1471-2458/11/264
Page 10 of 13is thus possible that never-use of condoms in our data is
indicative of a low level of health consciousness.
Women who ever had an STI and women who had
used hormonal contraceptives were more likely to have
attended screening, and they were also more likely to
have attended screening opportunistically. Being diag-
nosed with an STI requires a gynecological examination,
and purchase of hormonal contraceptives requires a pre-
scription, thus both predictors are associated with seeing
a physician. This may have influenced screening beha-
vior in two ways. First, a smear may have been taken as
part of the consultation regarding STI or hormonal con-
traceptives. This may also be an explanation for why
women who have given birth were more likely to attend
[17]. Second, women who use hormonal contraceptives,
or see a physician to be tested for STIs (some of which
are largely asymptomatic) ,m a yb em o r eh e a l t hc o n -
scious than women who do not and may hence be more
inclined to seek preventive healthcare.
Sociodemographic variables
Socio-economic status, as defined by social class, educa-
tion or income level, has consistently been shown to be
inversely related to the risk of cervical cancer [18-20].
Women of low socio-economic status also seem to have
a lower attendance to cervical screening [2,21,22]. Since
one of the motivations for organizing a screening pro-
gram is to decrease social inequalities in the use of pre-
ventive health services it is possible that the socio-
economic status differential is not equally relevant in
organized and opportunistic screening settings. Interest-
ingly, Eaker et al. [11] did not find an effect of socio-
economic status on attendance to screening in a Swed-
ish county with an organized screening program, and a
recent study from Great Britain indicates that self-
reported ever-attendance to organized cervical screening
may not depend strongly on a number of socio-eco-
nomic status variables, but is clearly affected by ethnicity
[23]. In a similar vein, we did not find a significant
effect of education in our fully adjusted model of non-
attendance versus attendance. However, we cannot con-
clude that socio-economic status plays no role in atten-
dance to cervical screening in an organized screening
setting with a relatively high attendance rate. Firstly, our
raw data and our age-adjusted analysis indicated that
the attendance rate was increasing with the level of edu-
cation. Secondly, educational level just fell short of sig-
nificance in the fully adjusted model of non-attendance,
and the contrast between the highest level of education
and the reference level for the term was in fact signifi-
cant even in this model. Thirdly, we only addressed edu-
cational level, which, although commonly used, does not
entirely capture socio-economic status. Thus, we may
conclude that in Norway, the educational level of
women is not strongly associated with non-attendance
to cervical screening when controlling for other factors.
This issue needs to be further investigated, and it would
be of interest to also include information on income,
social class and ethnicity in such an analysis.
Consistent with previous reports [5,24], we found that
single women were less likely to attend screening. Single
women may have experienced less encouragement from
a partner to seek preventive healthcare, and may also
have received less obstetric care. Like in most developed
countries [25], women in the youngest age group (25-29
years old) had a lower crude attendance rate than older
women. However, any effect of age disappeared in the
fully adjusted model of non-attendance versus atten-
dance, demonstrating that some other variables, also
associated with age, explained the lower attendance of
the youngest women. Many of the key variables that
influenced attendance in our models were also asso-
ciated with age, such as marital status and history of
giving birth.
Women increasingly relied on a reminder with
increasing age. This could result from experience with
the screening program. For instance, awareness that
reminders will be sent may result in an increased reli-
ance on reminders. Relatively older women may also
perceive themselves to be at a low risk of sexually trans-
mitted cervical disease and thus delay their screening
visits, or be more prone to underestimate the time since
they had their last smear.
Strengths and limitations
The representativeness of our study sample is enhanced
by the relatively high response rate and large sample
size. Moreover, the women invited to participate in the
survey were randomly drawn from the whole of Norway,
thus our results should be generalizable to the Norwe-
gian setting, and perhaps also to other countries with a
similar organized screening program. A further strength
is the quality-assured data on attendance. Many pre-
vious studies on attendance to cervical screening rely on
self-report of screening behavior [4,26], which is impre-
cise [27,28]. The complete registration of screening
attendance further allowed us to separately address
opportunistic versus reminded attendance in an orga-
nized screening setting and we are not aware that such
data has been published previously.
The study also has a number of limitations. First, the
attendance rate in the study sample was somewhat
higher than in the NCCSP. This is a universal problem
in population-based studies of attendance, probably
because those participating in a survey also are more
inclined to participate in screening. However, the discre-
pancy was relatively small, presumably due to the high
response rate in this study. We have limited information
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Page 11 of 13about the women who did not participate in the survey,
but they seemed similar to participants with respect to
age, region of residence and median household income
in the municipality in which they lived. Another limita-
tion is that our study sample was limited to 25-45 year
old women. The screening program in Norway targets
women up to the age of 69 and future studies should
address predictors of attendance among women above
age 45. Moreover, the study is cross-sectional, which is
suboptimal to address causality, and the data on the
women’s lifestyle was based on self-report which may be
prone to social desirability bias. Finally, we did not have
data on the ethnicity of respondents, which may be of
importance for attendance [23].
Conclusions
We show that attendance to cervical screening in an
organized screening program was positively associated
with awareness of screening, having had an STI, use of
hormonal contraceptives, use of condom, giving birth,
being a non-smoker and being married/cohabiting.
Since women with low awareness of screening were
more likely to be non-attendees, our results indicate
that increasing the awareness of cervical screening in
the population may increase the attendance rate. The
likelihood of being a reminded rather than an opportu-
nistic attendee was positively associated with age, aware-
ness of screening and cervical cancer, not having used
hormonal contraceptives and not having had an STI.
The lower awareness among opportunistic than
reminded attendees suggests that physicians may inform
their patients better when smears are taken at the physi-
cian’s initiative.
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